secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2026-08-12T15:50:09+00:00
Accession:  0001213900-26-088165
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma postpones BioKey share distribution to Aug 21, 2026
------------------------------------------------------------------

- Distribution of BioKey (Cayman) ordinary shares moved from Aug 3 to Aug 21, 2026.
- Record date remains July 24, 2026; ratio unchanged at 0.169464 BioKey shares per ABVC share.
- Ex-dividend date will be revised and announced after administrative, regulatory, and tax matters are completed.
- Company coordinated with Nasdaq, DTC, and transfer agent on revised distribution mechanics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/0001213900-26-088165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026088165/ea0301755-8ka1_abvc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-088165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer